Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-05

Clinical Trial Update: Drug Nephrotoxicity Amelioration by N-acetylcysteine [NA]

View source ↗

Summary

A completed clinical trial evaluated whether N-acetylcysteine can reduce drug-induced kidney injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Helwan University | Conditions: Drug-Induced Nephropathy | NA | Status: COMPLETED